A case of L-dopa-responsive parkinsonian syndrome after low-dose oral methotrexate intake.
Papapetropoulos
Spiridon
S
Department of Neurology, Regional University Hospital, Patras, Greece. spapapetropoulos@med.miami.edu
Argyriou
Andreas A
AA
Liossis
Stamatis-Nick C
SN
Daousis
Dimitrios
D
Katsoulas
Georgios
G
Apostolopoulos
Dimitrios
D
Chroni
Elisabeth
E
D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D008727:Methotrexate / Q000009:adverse effects*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced* / Q000188:drug therapy*; D016896:Treatment Outcome
D000978:Antiparkinson Agents; D018501:Antirheumatic Agents; D007980:Levodopa; D008727:Methotrexate